Epigenetic deregulation of DNA repair and its potential for therapy.
about
A critical re-assessment of DNA repair gene promoter methylation in non-small cell lung carcinomaThe clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancerO(6)-methylguanine-DNA methyltransferase in glioma therapy: promise and problemsModulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectivesEpigenetic disruption of cell signaling in nasopharyngeal carcinoma.Promoter hypermethylation of MGMT gene may contribute to the pathogenesis of gastric cancer: A PRISMA-compliant meta-analysis.Hypomethylation of the IGF2 DMR in colorectal tumors, detected by bisulfite pyrosequencing, is associated with poor prognosisWerner syndrome as a hereditary risk factor for exocrine pancreatic cancer: potential role of WRN in pancreatic tumorigenesis and patient-tailored therapy(-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells.Genes suppressed by DNA methylation in non-small cell lung cancer reveal the epigenetics of epithelial-mesenchymal transitionInfluence of PJ34 on the genotoxicity induced by melphalan in human multiple myeloma cells.MGMT promoter methylation, loss of expression and prognosis in 855 colorectal cancers.Fanconi anemia genes in lung adenocarcinoma- a pathway-wide study on cancer susceptibilityGrape seed proanthocyanidins reactivate silenced tumor suppressor genes in human skin cancer cells by targeting epigenetic regulators.Extended survival of glioblastoma patients after chemoprotective HSC gene therapyIdentification of Methylation-Driven, Differentially Expressed STXBP6 as a Novel Biomarker in Lung Adenocarcinoma.Review of the alterations in DNA methylation in esophageal squamous cell carcinoma.The continuing evolution: biology and treatment of brain tumors.MGMT promoter methylation status in brain metastases from colorectal cancer and corresponding primary tumors.Combined modality approaches in the management of adult glioblastoma.The Bcl-2 inhibitor Obatoclax overcomes resistance to histone deacetylase inhibitors SAHA and LBH589 as radiosensitizers in patient-derived glioblastoma stem-like cells.Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.Histone acetylation patterns of typical and atypical pituitary adenomas indicate epigenetic shift of these tumours.Pancreatic Adenocarcinoma Associated With Werner's Syndrome (Adult-Onset Progeria).Cancer epigenetics: new therapies and new challenges.PPAR signaling pathway may be an important predictor of breast cancer response to neoadjuvant chemotherapy.S-allylcysteine suppresses ovarian cancer cell proliferation by DNA methylation through DNMT1.
P2860
Q21558626-A027F7C3-FCF1-477F-BCF4-2E4F5B6D7DC9Q26766285-80614FBC-9610-4594-8A4B-3F0DA10F82F7Q26853112-68F7E3CD-3C13-4001-9F50-28EB40678F43Q30570945-C129C03B-57A6-45EE-A1B9-3D3B1118DA56Q33579472-AF72EEBE-8D58-4CEB-85D4-A6226DBEE1A7Q33627145-65F20AEA-C83A-4DBA-B833-E84EFE77B278Q34372543-5486D68F-A531-4774-890C-FAD20B09CD66Q34582178-EA12576F-52EF-49A7-8B5C-8CE6F58F3BD3Q34734091-201F962D-E685-4FD0-A639-B9820DD32328Q34984574-08947D0E-2593-4E26-8369-8A682E67D2C2Q35582803-59A061CB-B596-469F-8960-7F95B8674C02Q35755035-0C5410B0-73E9-4329-B350-DF13D7543366Q35913754-96C871E3-5112-421C-9F2D-318C1375F56CQ36124032-D86AB717-9763-4A85-B008-2FDC1A875C1CQ36834118-B37B9669-C059-4AB2-B394-ACE1862FDD9AQ37642592-02C81520-3E22-4C18-98F2-19D8728E27E7Q38071897-5AD2EDBD-61BD-4BE2-8C8A-B7C4BACEA6FFQ38230516-33F95975-17D1-47CC-9397-644B9A6B8A83Q39022551-D71B3C54-7954-45B6-BF76-BD65281CB760Q42151501-58970D00-DE5E-43CE-84FE-A820FA206353Q42277834-FA97D345-C44D-406C-A638-0C8255254FE0Q42444119-5717D3DD-9229-4434-AC61-17DBFFA087D7Q42595742-401653D1-2B01-48A2-9E7B-B163B244C562Q42709819-1BC29BA4-505A-427B-A575-B41870B04A53Q43226742-A4B9DBD4-4AD6-4361-9A9A-10E458ED3ACFQ44727677-F61B7CC3-C363-445F-8373-FD3A44AD41DCQ54966161-23930A24-CFEF-42ED-8FE8-6892DB6C5ED3
P2860
Epigenetic deregulation of DNA repair and its potential for therapy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetic deregulation of DNA repair and its potential for therapy.
@en
Epigenetic deregulation of DNA repair and its potential for therapy.
@nl
type
label
Epigenetic deregulation of DNA repair and its potential for therapy.
@en
Epigenetic deregulation of DNA repair and its potential for therapy.
@nl
prefLabel
Epigenetic deregulation of DNA repair and its potential for therapy.
@en
Epigenetic deregulation of DNA repair and its potential for therapy.
@nl
P2093
P1476
Epigenetic deregulation of DNA repair and its potential for therapy.
@en
P2093
Anastasia Murat
Davide Sciuscio
Marc Levivier
Monika E Hegi
Roger Stupp
P304
P356
10.1158/1078-0432.CCR-08-1169
P407
P577
2009-08-11T00:00:00Z